92 related articles for article (PubMed ID: 9369366)
1. Involvement of nitric oxide in development of tail-tremor induced by repeated nicotine administration in rats.
Suemaru K; Kawasaki H; Gomita Y; Tanizaki Y
Eur J Pharmacol; 1997 Sep; 335(2-3):139-43. PubMed ID: 9369366
[TBL] [Abstract][Full Text] [Related]
2. Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Suemaru K; Kawasaki H; Oishi R; Gomita Y; Tanizaki Y
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):571-5. PubMed ID: 9151294
[TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of anti-tremorogenic drugs using nicotine-induced tail-tremor model and elucidation of the mechanism].
Suemaru K; Araki H; Gomita Y
Yakugaku Zasshi; 2001 Apr; 121(4):259-64. PubMed ID: 11305042
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice.
Ohno M; Watanabe S
Eur J Pharmacol; 1995 Feb; 275(1):39-44. PubMed ID: 7539765
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of nicotine-induced seizures in mice.
Damaj MI; Glassco W; Dukat M; Martin BR
J Pharmacol Exp Ther; 1999 Dec; 291(3):1284-91. PubMed ID: 10565853
[TBL] [Abstract][Full Text] [Related]
7. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
[TBL] [Abstract][Full Text] [Related]
8. Involvement of 5-hydroxytryptamine(1A) receptors in nicotine-induced tail tremor in rats.
Suemaru K; Araki H; Gomita Y
Eur J Pharmacol; 2000 Nov; 408(1):19-23. PubMed ID: 11070179
[TBL] [Abstract][Full Text] [Related]
9. The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice.
Sahraei H; Falahi M; Zarrindast MR; Sabetkasaei M; Ghoshooni H; Khalili M
Eur J Pharmacol; 2004 Oct; 503(1-3):81-7. PubMed ID: 15496300
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of tail-tremor induced by nicotine in rats.
Suemaru K; Oishi R; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):153-7. PubMed ID: 7990972
[TBL] [Abstract][Full Text] [Related]
11. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
Hong SK; Jung IS; Bang SA; Kim SE
Neurosci Lett; 2006 Dec; 409(3):220-3. PubMed ID: 17046158
[TBL] [Abstract][Full Text] [Related]
12. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
Zakharova ES; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
[TBL] [Abstract][Full Text] [Related]
13. Nicotine-induced tail-tremor and drug effects.
Gomita Y; Suemaru K; Furuno K; Araki Y
Pharmacol Biochem Behav; 1989 Dec; 34(4):817-21. PubMed ID: 2576144
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats.
Suemaru K; Kawakami Y; Araki H; Gomita Y; Tanizaki Y
Acta Med Okayama; 1998 Feb; 52(1):49-53. PubMed ID: 9548994
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal.
Adams ML; Cicero TJ
Eur J Pharmacol; 1998 Mar; 345(2):R1-2. PubMed ID: 9600643
[TBL] [Abstract][Full Text] [Related]
16. Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.
Eblen F; Löschmann PA; Wüllner U; Turski L; Klockgether T
Eur J Pharmacol; 1996 Mar; 299(1-3):9-16. PubMed ID: 8901001
[TBL] [Abstract][Full Text] [Related]
17. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release.
Fedele E; Varnier G; Ansaldo MA; Raiteri M
Br J Pharmacol; 1998 Nov; 125(5):1042-8. PubMed ID: 9846643
[TBL] [Abstract][Full Text] [Related]
18. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
19. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of anti-tremorogenic drugs--nicotine-induced tail-tremor model].
Suemaru K; Kawasaki H; Gomita Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):123-7. PubMed ID: 9278937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
